Retinitis Pigmentosa
Causes, Diagnosis & Treatment
Seiten
2010
Nova Science Publishers Inc (Verlag)
978-1-60876-884-4 (ISBN)
Nova Science Publishers Inc (Verlag)
978-1-60876-884-4 (ISBN)
Retinis Pigmentosa (RP) includes a group of progressive hereditary retinal diseases involving degeneration of rod and cone photoreceptors, predominantly the former, and is one of the leading causes of hereditary blindness in the developed world. This book highlights the research done in this field.
Retinis Pigmentosa (RP) includes a group of progressive hereditary retinal diseases involving degeneration of rod and cone photoreceptors, predominantly the former, and is one of the leading causes of hereditary blindness in the developed world. Clinical symptoms include nyctalopia, progressive visual field loss, and deterioration in visual acuity in adolescence. It affects one in 3000-5000 individuals and can be caused by mutations in more than 40 genes. In addition, Retinitis Pigmentosa may exist either alone (nonsyndromic) or as part of a neurological or systemic disorder, such as Usher's syndrome and Infantile Refsum's disease. There are few effective clinical treatments for retinitis pigmentosa which affects an estimated 1.5 million individuals world-wide. However, understanding the histopathologic changes occurring in RP is critical to understanding the rationale for current therapies, as well as to develop future therapies. This book highlights the most recent research done in the field.
Retinis Pigmentosa (RP) includes a group of progressive hereditary retinal diseases involving degeneration of rod and cone photoreceptors, predominantly the former, and is one of the leading causes of hereditary blindness in the developed world. Clinical symptoms include nyctalopia, progressive visual field loss, and deterioration in visual acuity in adolescence. It affects one in 3000-5000 individuals and can be caused by mutations in more than 40 genes. In addition, Retinitis Pigmentosa may exist either alone (nonsyndromic) or as part of a neurological or systemic disorder, such as Usher's syndrome and Infantile Refsum's disease. There are few effective clinical treatments for retinitis pigmentosa which affects an estimated 1.5 million individuals world-wide. However, understanding the histopathologic changes occurring in RP is critical to understanding the rationale for current therapies, as well as to develop future therapies. This book highlights the most recent research done in the field.
Preface; Experimental Therapy for Retinitis Pigmentosa; Retinitis Pigmentosa; Great Expectations: RPE65 Mutations in South Africa; Diagnosis and Treatment of Retinitis Pigmentosa Based on the Pathology; Mutational Analysis of RHO and RDS Genes in Patients with Retinitis Pigmentosa from Volga-Ural Region of Russia; Physiopathology of Retinal Degeneration in Rd1 Mouse Model of Retinitis Pigmentosa: TGF-B1, Proteinases & Oxidative Stress Mechanisms; Visual Training in Retinitis Pigmentosa Patients: Neural Plasticity & Function Recovery; Index.
| Erscheint lt. Verlag | 1.7.2010 |
|---|---|
| Zusatzinfo | Illustrations |
| Verlagsort | New York |
| Sprache | englisch |
| Maße | 230 x 155 mm |
| Gewicht | 328 g |
| Themenwelt | Medizin / Pharmazie ► Gesundheitsfachberufe |
| ISBN-10 | 1-60876-884-8 / 1608768848 |
| ISBN-13 | 978-1-60876-884-4 / 9781608768844 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
CHF 54,60
Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 89,95
Wenn Kinder nicht oder kaum verständlich sprechen
Buch | Softcover (2022)
Schulz-Kirchner (Verlag)
CHF 19,95
